verapamil has been researched along with tretinoin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Galkowska, H; Olszewski, WL | 2 |
| Mochizuki, T; Okazaki, T; Sawada, H; Tashima, M; Uchino, H | 1 |
| Davey, MW; Davey, RA; Kidman, AD; Su, GM | 1 |
| Ikeda, Y; Kizaki, M; Koeffler, HP; Matsushita, H; Morikawa, M; Muto, A; Nakajima, H; Shimada, M; Takayama, N; Ueno, H; Yamazoe, Y | 1 |
| Gao, ZY; Lee, VM; Matschinsky, FM; Stwora-Wojczyk, MM; Wolf, BA; Xu, G | 1 |
| Arcangeli, A; Cassulini, RR; Crociani, O; Curia, G; Florio, T; Gurrola, G; Lecchi, M; Masi, A; Olivotto, M; Possani, LD; Redaelli, E; Rosati, B; Schettini, G; Wanke, E | 1 |
| Takeshita, A | 1 |
| Breier, A; Brtko, J; Macejová, D; Sedlák, J; Seres, M; Sulová, Z | 1 |
| He, Q; Hu, Y; Wang, W; Yan, Y; Yang, B; Yang, W; Zhang, L; Zhu, D | 1 |
| Bohacova, V; Breier, A; Brtko, J; Macejova, D; Stetka, J; Sulova, Z | 1 |
| Cheon, SA; Chung, JF; Joo, MY; Kim, B; Kim, KH; Lee, SJ; Park, SH; Park, TJ; Seo, ES; Sood, AK; Yang, JS; Yoon, CJ | 1 |
2 review(s) available for verapamil and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
Topics: Alkyl and Aryl Transferases; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Cyclosporine; Cytarabine; Daunorubicin; Drug Design; Farnesyltranstransferase; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Nucleosides; Oxides; Prognosis; Radioisotopes; Remission Induction; Tetrahydronaphthalenes; Topoisomerase Inhibitors; Tretinoin; Verapamil | 2003 |
17 other study(ies) available for verapamil and tretinoin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Spontaneous cluster formation of dendritic (veiled) cells and lymphocytes from skin lymph obtained from dogs with chronic lymphedema.
Topics: Animals; Anti-Inflammatory Agents; Dendritic Cells; Dogs; Edetic Acid; Immunosuppressive Agents; Lidocaine; Lymph; Lymphatic System; Lymphedema; Lymphocytes; Skin; Tretinoin; Verapamil | 1992 |
Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation.
Topics: Calcitriol; Calcium; Cell Differentiation; Cell Division; Cell Line; Dimethyl Sulfoxide; Ethers; Gallic Acid; Humans; Ionomycin; Leukemia, Myeloid, Acute; Tetradecanoylphorbol Acetate; Tretinoin; Verapamil | 1986 |
Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Methionine Sulfoximine; Tretinoin; Tumor Cells, Cultured; Verapamil; Vinblastine | 1994 |
Skin dendritic cell-lymphocyte interactions in autologous system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azides; Cell Adhesion; Dendritic Cells; Deoxyribonucleases; Dogs; Edetic Acid; Endopeptidases; Epidermis; Heparin; Immunosuppressive Agents; Lidocaine; Lymph; Lymphedema; Lymphocytes; Neuraminidase; Sodium Azide; Tretinoin; Verapamil | 1993 |
Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein.
Topics: Antigens, Differentiation; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Biotransformation; Calcium-Binding Proteins; Calgranulin A; Calgranulin B; Cell Differentiation; Clotrimazole; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Granulocytes; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Microsomes; Molecular Sequence Data; Neoplasm Proteins; Neoplastic Stem Cells; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Neoplasm; Tretinoin; Verapamil | 1996 |
Retinoic acid induction of calcium channel expression in human NT2N neurons.
Topics: Base Sequence; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Differentiation; DNA Primers; Gene Expression; Homeostasis; Humans; Intracellular Fluid; Neurons; Nifedipine; Phenotype; RNA, Messenger; Tretinoin; Tumor Cells, Cultured; Verapamil | 1998 |
Isolation of a long-lasting eag-related gene-type K+ current in MMQ lactotrophs and its accommodating role during slow firing and prolactin release.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brain; Calcium Channel Blockers; Cation Transport Proteins; Cell Line; Computer Simulation; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Membrane Transport Proteins; Models, Neurological; Patch-Clamp Techniques; Pituitary Gland; Potassium; Potassium Channels; Potassium Channels, Voltage-Gated; Prolactin; Rats; RNA; Scorpion Venoms; Tretinoin; Verapamil | 2002 |
Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Death; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Leukemia; Mice; Retinoid X Receptors; RNA, Messenger; Tretinoin; Verapamil; Vincristine | 2008 |
Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Biological Transport; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid; Piperazines; Proto-Oncogene Proteins c-mdm2; Proto-Oncogene Proteins c-myc; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; RNA Interference; Time Factors; Transfection; Tretinoin; Tumor Suppressor Protein p53; U937 Cells; Verapamil | 2012 |
Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells.
Topics: Alitretinoin; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Leukemia L1210; Receptors, Retinoic Acid; Retinoid X Receptors; Tretinoin; Verapamil | 2014 |
NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil.
Topics: Animals; Female; Fibrosis; Heptaminol; Hyperplasia; Killer Cells, Natural; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pindolol; Skin; Tetradecanoylphorbol Acetate; Tretinoin; Verapamil | 2016 |